Beijing-headquartered Chinese private equity firm Hony Capital has completed a partial exit from Hong Kong-listed Chinese generic drugs maker CSPC Pharmaceutical Group, selling 705.88 million shares for a total proceeds of HK$4.41 billion (US$570 million), according to a regulatory filing. Hony Capital unloaded 600 million CSPC shares to other third-party investors and 105.88 million shares […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.